Canine urethral sphincter pressure profile under incremental inflation of an artificial cuff: a cadaver study by Milodowski, E J et al.
  
RVC OPEN ACCESS REPOSITORY – COPYRIGHT NOTICE 
 
This author’s accepted manuscript may be used for non-commercial purposes in accordance 
with Wiley Terms and Conditions for Self-Archiving. 
The full details of the published version of the article are as follows: 
 
TITLE: Canine urethral sphincter pressure profile under incremental inflation of an artificial 
cuff: a cadaver study 
AUTHORS: E. J. Milodowski, E. J. Friend, N. Granger, I. C. P. Doran 
JOURNAL: Journal of Small Animal Practice 
PUBLISHER: Wiley 
PUBLICATION DATE: 14 November 2018 (online) 
DOI: https://doi.org/10.1111/jsap.12961  
TITLE 
Canine urethral sphincter pressure profile under incremental inflation of an artificial cuff: a 
cadaver study. 
AUTHOR LIST 
Emily Jayne Milodowski BSc BVSc PGDipVCP MRCVS 
Current address: Bristol Veterinary School, Faculty of Health Sciences, University of Bristol, 
University Walk, Bristol, BS8 1TD 
Edward James Friend BVetMed CertSAS BVM DipECVS MRCVS 
Current address: Highcroft Referral Hospital, Whitchurch, Bristol, United Kingdom.   
Previous affiliation: Vale Referrals, The Animal Hospital, Stinchcombe, Dursley, Gloucestershire, 
GL11 6AJ.   
Nicolas Granger DVM PhD DipECVN FHEA MRCVS 
The Royal Veterinary College, Hertfordshire, AL9 7TA, UK 
& Bristol Veterinary Specialists at Highcroft, Bristol, BS14 9BE, UK. 
Ivan Carl Patrick Doran BVSc CertSAS DSAS(Soft Tissue) MRCVS 
Current address: Highcroft Referral Hospital, Whitchurch, Bristol, United Kingdom. 
Previous affiliation: School of Veterinary Sciences, University of Bristol, Langford House, Langford, 
Bristol BS40 5DU 
Corresponding author email address: Ivan.Doran@cvsvets.com 
Corresponding author telephone: 01275 838 473 
ACKNOWLEDGEMENTS 
The authors would like to thank Dr Delphine Holopherne-Doran for helping with equipment, and the 
staff of the Post Mortem Room at the University of Bristol, Department of Clinical Veterinary 
Science for accommodating the study.  The Artificial urethral sphincters used in the study were 
provided by DOCXS Biomedical Products (California, USA). 
  
SUMMARY 
Objectives: This preliminary study aimed to determine if artificial urethral sphincter filling volume is 
proportional to peak pressure exerted on the urethra.  
Methods: Urethral pressure profilometry was performed in five female, medium sized, mixed-
breed canine cadavers following artificial urethral sphincter placement.  Maximum urethral pressure 
was recorded following sequential incremental inflation of 0.15mL and compared 
to baseline pressure and between dogs using a two-way ANOVA.  
Results: Artificial urethral sphincter placement in cadavers was associated with an increase in 
urethral pressure, which was significantly correlated with artificial urethral sphincter volume. The 
correlation was non-linear and demonstrated considerable individual variation. Maximum urethral 
pressures after artificial urethral sphincter placement exceeded those reported in conscious continent 
dogs within a narrow volume range, in which a 0.15mL infusion more than doubled  maximal urethral 
pressures. 
Clinical implications: Rapid increases in urethral pressure from the artificial urethral sphincter over a 
small range of filling volumes (0.15mL increments) might explain why some clinical cases can 
become suddenly dysuric following incremental inflations. We suggest that smaller increments of 
filling (0.05-0.1mL) may achieve finer pressure control. 
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INTRODUCTION 
Urinary incontinence may be defined as involuntary loss of urine during bladder filling or 
storage (Reichler and Hubler, 2014).  Urethral sphincter mechanism incompetence (USMI) is the 
most common cause of urinary incontinence in dogs (Holt, 1990a) with a prevalence of 20% in 
neutered bitches (Arnold et al. 1989). Neutering is a confirmed risk factor (Holt and Thrusfield, 
1993).  The pathophysiology of USMI in neutered dogs is incompletely understood, although reduced 
urethral pressure is implicated, since significant reduction in urethral pressures have been recorded in 
incontinent compared to continent bitches (Arnold, 1997).  Salomon and colleagues (2006) reported 
that the mean urethral closing pressure significantly reduces post-spaying with a lag period of at 
least 6 months.  Structural urethral changes, including reduced smooth muscle mass and increased 
collagen content, have also been described (Noel et al., 2010).  
USMI is treated medically with the α-adrenergic agonist phenylpropanolamine and 
estriol with success varying from 75 to 95% (Mandigers and Nell, 2001, Bacon et al., 2002, Noel et 
al., 2010). Surgical treatments for USMI are usually pursued when medical treatment fails (Claeys et 
al., 2010a).  Described techniques include colposuspension (Holt, 1990b), urethropexy (White, 
2001, Martinoli et al., 2014), sphincter bulking (Byron et al., 2011), trans-obturator vaginal 
tape (Claeys et al., 2010b) and artificial urethral sphincters (AUS).  Colposuspension is the 
surgery most commonly performed for treatment of USMI, and its long-term outcome is successful in 
53% cases (Holt, 1990b).   
The use of AUS for management of urinary incontinence in dogs by manipulating urethral pressure 
profiles was first reported in cadavers (Adin et al., 2004).  A significant increase in both urethral 
closing pressure and cystourethral leak point pressure was recorded at 50% occlusion compared to 
baseline.  Adin and co-workers (2004) measured‘percentage occlusion’ of the AUS device ex vivo by 
measuring digital images of the AUS lumen at various increments of filling.  This 
was then correlated with urethral closing pressures achieved after AUS placement and inflation to the 
predetermined volumes of filling equivalent to 0%, 25% and 50% occlusion.  However, it is difficult 
to interpretthese results when an AUS is already in situ in a patient and the level of functional 
urethral occlusion cannot easily be determined.  A more useful parameter would be the occluder 
filling volume correlated with pressure exerted on the urethra, which can be measured clinically by 
profilometry, as this may help to direct clinicians on how much AUS inflation is required after 
placement.  
Outcomes following AUS placement have been reported in prospective (Rose et al., 2009) and 
retrospective (Reeves et al., 2012, Delisser et al., 2012, Currao span style="font-family:Verdana; 
font-style:italic">et al., 2013, Gomes et al., 2018, Morgan et al., 2018) studies.   Overall, AUS 
placement has a good outcome with up to 80% of cases reported ascompletely continent, without the 
need for additional medical treatment at 12 months post-operatively (Gomez et al., 
2018). Minor complications were seen in 30 to 81.8% of cases at varying periods post-operatively 
and resolved with either no, or minimally-invasive, treatment. Major complications such as urethral 
obstruction, requiring surgical intervention, were recorded in 7 to 27% of cases and these were 
managed by AUS deflation or removal (Delisser et al., 2012, Reeves et al., 2012, Currao et al., 2013, 
Gomes et al., 2018).  Port-dislodgement, and peri-AUS fibrosis requiring surgical correction have 
also been reported (Morgan et al., 2018). 
Study Aims 
AUSs are typically placed uninflated and repeated inflations of 0.1 to 0.5mL of saline are carried out 
on persistently incontinent dogs over prolonged follow-up periods (Delisser et al. 2012).   Clinical 
experience of using AUSs has shown that it can be challenging to 
manage persistent incontinence via sequential cuff inflation without inducing dysuria in 
dogs (Gomes et al., 2018).  The aim of this study was to perform a preliminary investigation 
to determine if the volume of AUS filling is proportional to the peak pressure exerted on the urethra, 
and investigate whether the relationship between AUS filling and pressure exerted is linear. In order 
to derive clinically useful data, small increments of infusion volume were used to reflect the range of 
volumes used clinically (0.1mL to 0.5mL). 
  
MATERIALS AND METHODS 
Cadavers 
Five female, medium-sized (15-22kg), mixed breed (four Staffordshire bull terrier crosses, one collie 
cross) dogs were euthanised for reasons not related to this study.  Cadavers were obtained 
frozen and defrosted for 48 hours before testing took place.  A ventral midline coeliotomy was 
performed from umbilicus to the pubic brim, with the cadaver supported in dorsal recumbency.  The 
bladder was retracted cranio-ventrally to expose the urethra and vagina.  An episiotomy was 
performed and a urinary catheter was placedto identify the urethra.  The peri-vaginal fat 
was reflected cranially, and blunt dissection was performed around the proximal urethra 
approximately 2 cm caudal to the bladder neck.   This zone of dissection was extended sufficiently 
along the urethral axis that the full width of the AUS could be passed around the urethra without the 
cuff becoming pinched by tissues.  The circumference of the urethra at this site was measured in each 
cadaver using a piece of free tape and loosely placing iaround the urethra.  The corresponding 
length was measured against a ruler.  A 10mm (internal diameter) x 14mm (width) AUS (DOCXS 
Biomedical Products, California, USA) was inflated maximally with Hartmann’s solution to displace 
any air, test for leakage and to unstick any areas of adhesion between the silicone leaves of the 
cuff.  The fluid was removed to leave onlythe priming volume before placement.  The uninflated AUS 
was placed around the proximal urethra and sutured in place with 4-0 Nylon.  A stab incision was 
made in the lateral body wall adjacent to the occluder, and the AUS connector tubing was 
tunnelled into the subcutaneous space lateral to the body wall where it was connected to an injection 
port. 
  
Urethral pressure profilometry 
Urethral pressure profiles (UPP) were measured as previously described (Life-Tech, 2008, Goldstein 
and Westropp, 2005).  Briefly, a 7F double-lumen UPP catheter (Life-Tech, Vermont USA) was used 
to generate a urethral pressure profile whist being withdrawn from a start point in the bladder neck 
into the urethra and past the site of the AUS.  An automated syringe driver (Alaris GH, CareFusion, 
Basingstoke, UK), connected to the UPP catheter under tension, was set up with a primed 
10mL syringe discharging at a rate of300mL/h to withdraw the UPP catheter at a constant rate of 
0.5mm/s (Goldstein and Westropp, 2005).  The UPP catheter was attached to a 3-way 
tap and connected to a fluid infusion pump and to a pressure monitor (SurgiVet Advisor Vital Signs 
Monitor, Smiths Medical, Massachusetts USA) via a fluid column.  The pressure sensor was zeroed to 
atmospheric pressure at the level of the urethra.  The UPP catheter was inserted into the urethra, 
palpated and positioned with the pressure transducer cranial to the bladder neck, the approximate 
distance of the transducer from the cranial edge of the AUS was recorded.  The catheter was infused 
with isotonic fluids (Hartmann’s) at a rate of 2mL/min (Goldstein and Westropp, 2005).  In 
each cadaver, profilometry was performed before placement of the AUS, following placement of 
the AUS with a priming volume, and with incremental doses of 0.15mL reflecting a clinical approach 
to AUS inflation (Delisser et al., 2012).  Pressure readings were recorded at 10 second intervals as the 
catheter was withdrawn from the urethra; each interval represented a 5mm 
distance.  Maximal observed urethral pressures were recorded for each increment of occluder volume. 
Each volume was tested in triplicate.  Separate occluders and UPP catheters were used in each 
cadaver, and UPP was recorded with the cadaver in dorsal recumbency. 
  
Statistics 
Statistics were carried out using GraphPad Prism 5. The effect of incremental inflation of the AUS by 
0.15mL inflations was measured using a two-way ANOVA.  Changes in urethral pressure measured at 
each level of inflation were compared to the background urethral pressure with the AUS placed, but 
uninflated.  A/span>P value of 0.05 was used to indicate a significant difference. Urethral pressure 
values achieved following AUS inflation were described as higher or lower than those pressures 
recorded in clinically normal dogs, as reported by Fischer and co-workers (2003). 
  
RESULTS 
The effect of AUS placement on UPP 
Urethral size at the site of AUS placement ranged from 15-25 mm (median 20 mm; Table 1).  Dogs 2, 
3 and 5 showed no change in urethral pressure after placement of an uninflated AUS. In Dog 1, a 
reduction in urethral pressure from 15.7 to 11.3 cm H2O was detected after AUS placement but this 
difference in pressure profile did not coincide with the position of the AUS.  Dog 4 demonstrated a 
doubling of urethral pressure from 13.3 before AUS placement to 27.0 cm H2O after placement of an 
uninflated AUS. This increase in urethral pressure was at the approximate position of the AUS, 
indicating that the uninflated AUS may have been exerting pressure at this point.  
Effect of AUS inflation on maximal urethral pressure 
An increase in maximal urethral pressure (above background levels) was observed in each cadaver 
following incremental inflation of the AUS (P <0.0001) (Table 1). When represented graphically, the 
increase in maximal urethral pressure followed a sigmoid curve (Figure 1): (i) a first portion of the 
curve representing the infused volume needed to obtain a significant change in maximal urethral 
pressure above the uninflated pressure; (ii) an exponential rise in pressure with incremental inflation 
of liquid; (iii) a plateau phase. 
During the first phase of the inflation, the AUS significantly increases maximum urethral pressure 
above baseline when the cuff is uninflated but the magnitude of this effect was variable between 
dogs: Dog 1 required 0.9mL, Dog 2 required 0.3mL, Dog 3 required 0.6mL, Dog 4 required 0.75mL 
and Dog 5 required 0.6mL. 
The clinical implications of the pressure changes recorded are best understood when compared to 
normal urethral pressure; 146.5+/- 41.9 cm H2O (Fischer et al., 2003).  According to this data, the 
minimum urethral pressure in normal, conscious, continent dogs was 104.6 cm H2O.  This pressure 
could be achieved after AUS placement andincremental inflation in each cadaver (Figure 1), although 
the target volume of inflation varied between dogs.  From a clinical stand point, the variations 
observed were large because in some dogs, a 0.15mL infusion led to more than a doubling of 
the maximal urethral pressure: (i) in Dog 1 the maximum urethral pressure was 63.7 cm H2O at 
0.9mL of filling and increased to 159.3 cm H2O when the AUS was filled to 1.05mL; (ii) in Dog 2 an 
increase in urethral pressure from 84.3 cm H2O to 187.7 cm H2O occurred when the AUS was filled 
from 0.3mL to 0.45mL; (iii) in Dog 3 the maximum urethral pressure at 0.75 mL of inflation was 
recorded as 62.0 cm H2O and increased to 132.7 cm H2O after the addition of another 0.15mL to the 
AUS.  In other dogs, the relative change in pressure was smaller but did reach values above normal 
urethral pressure for a single 0.15mL increment: (i) in Dog the maximum urethral pressure at 0.75 mL 
of inflation was 98.7 cm H2O, increasing to 193.3 cm H2O after another 0.15mL inflation to 0.9 
mL; (ii) Dog 5, which demonstrated the smallest increase in urethral pressure to reach the normal 
range,  recorded a maximum urethral pressure of 56.0 cm H2O at 0.6mL of 
filling increasing to 108.3 cm H2O when the AUS was filled to 0.75mL.  Following incremental 
filling of the AUS, the urethral pressure profiles indicated that increases in pressure exerted on the 
urethra are localised to the section of the urethra surrounded by the AUS (data not shown).  
  
DISCUSSION 
While this is not the first study to assess the use of AUS in canine cadavers, no previous study has 
correlated incremental AUS inflation with the maximal pressure exerted on the urethra.  Normal 
urethral pressure in conscious, continent dogs has been reported as 146.5+/- 41.9 cm H2O (Fischer et 
al., 2003).  As shown by Adin and colleagues (2004), the urethral pressure observed in a cadaver 
model is much lower than that in conscious dogs.  Despite this, the effect of hydraulic AUSs in the 
treatment of USMI is independent of muscle tone, and cadavers may still be used to 
demonstrate relevant patterns of response, even if the recorded pressures are not within 
physiologically normal limits (Adin et al., 2004). Following this it was considered more acceptable, in 
the initial instance, to perform preliminary investigations using cadavers rather than studying live 
companion dogs. 
  
The results of this study demonstrate that the placement of an AUS around the proximal urethra is 
associated with incremental increases in urethral pressure capable of exceeding 300 cm H2O.  This 
is above normal resting urethral pressure (Fischer et al., 2003).  However, the 
relationship observed is both non-linear and considerably variablebetween cadavers.  This finding 
supports clinical observations that some USMI cases treated with AUSs will require greater cuff 
inflation volumes than others to reach continence, with some cases becoming continent following 
AUS placement without any additional inflation, while others necessitate repeated deflations or 
removal (Reeves et al., 2012, Delisser et al., 2012, Gomes et al., 2018, Morgan et al., 
2018).  This important patient variation in addition to the intensive follow-up management and 
potential need to resolve complications makes the placement of AUS devices undesirable for 
most primary care practices. 
The clinical relevance of a ‘significant increase’ in urethral pressure following inflation of 
the AUS from the uninflated position is questionable, because it does not necessarily represent an 
effect seen clinically.  Incontinence occurs when resting bladder pressure exceeds urethral pressure, 
therefore a resting urethral pressure exceeding bladder pressure is required to prevent 
urinary incontinence in the nomal dog.  This pressure level (146.5+/- 41.9 cm H2O) would appear to 
be an appropriate therapeutic aim when inflating AUSs to treat USMI (assuming there is no 
underlying detrusor instability).  Thus, a better approach to answer the clinical question (of whether a 
specific AUS volume can be recommended for treatment of USMI) would be 
to identify the volume of AUS inflation required to generate a urethral pressure exceeding that of 
resting urethral pressure in normal dogs.  Figure 1 shows the correlation of AUS volume on maximal 
urethral pressure compared to the above stated range of ‘normal resting urethral pressures’ as 
described by Fischer and colleagues (2003).  In each cadaver, this urethral pressure was achieved by 
incremental AUS inflation.  This result indicates that AUS is an effective means to treat 
incontinence by focally and artificially restoring urethral pressure.  In addition to achieving ‘normal 
urethral pressure’, the graphs also demonstrate that this pressure is exceeded over a small increase of 
AUS volumes.  An increase in urethral pressure of 74- 97 cm H2O could be achieved by a single 
incremental increase of 0.15mL in the cadavers to achieve a maximum pressure exceeding 100 cm 
H2O.  The pattern of a rapid increase in urethral pressure exerted by the AUS over a small range of 
filling volumes might explain why some clinical cases can become suddenly dysuric following 
incremental AUS inflations despite previous incontinence, and smaller increments of filling over this 
range of urethral pressures may achieve finer pressure control. 
There are many limitations to this study that restrict the drawing of inferences regarding the clinical 
significance of AUS inflation volume on urethral pressure in live dogs.  Foremost, from a study size 
of five cadavers it is difficult to relate the results to a general population.  There is, arguably, limited 
value in comparing UPP recorded in cadavers to those recorded in conscious dogs as they are known 
to be different (Adin et al., 2004).  In a conscious dog muscle 
tone, abdominal and pelvic pressures may influence UPP but cannot be assessed in a cadaver 
model.  Despite this, correlations between AUS volume and maximal urethral pressure, and patterns 
of responses of individual dogs are still relevant, and are a useful preliminary 
investigation before conducting clinical studies.  In this study, all cadavers demonstrate a significant 
increase in urethral pressure from baseline (uninflated cuff in position) at 0.9mL.  Clinically, a mean 
volume of 0.4mL (0.1-0.7mL) is required to achieve maximal continence (Reeves et al., 2012).  This 
is a smaller volume than seen in this cadaver study, although in three of five cadavers the normal 
urethral pressure range was reached with 0.75mL inflation, and one dog responded adequately to an 
inflation of 0.3mL.  This difference in volume requirement between cadavers and clinical cases is 
most likely due to thertificially low basal urethral pressures in the cadavers.  It could be expected, 
therefore, that higher resting urethral pressures, even in an incontinent dog, will require a 
smaller pressure exerted by an AUS to achieve continence.  In addition, irritation and tissue disruption 
due to surgical placement of the AUS in clinical cases may induce a degree of muscular spasm in the 
early postoperative period whilst periurethral fibrosis may develop at a later stage (Morgan et al., 
2018), also contributing to increasing urethral tone post-operatively.   
The magnitude of effect of AUS inflation was variable between cadavers.  In the present study, a 
standard sized (10x14mm) AUS was placed on each cadaver irrespective of urethral 
circumference (range 15-25mm).  AUS size selection in clinical cases has previously been based on 
approximate measurement of the circumference of the urethra and placement of an AUS with equal or 
larger circumference (Reeves et al., 2012).  Whereas Currao and co-workers (2012) reported a 
surgical technique whereby AUS luminal diameter size was calculated as 50% of the urethral 
circumference at the site of placement, although there is  no consensus for selection of, and little 
evidence to recommend,specific AUS sizes in dogs.  The use of a single size of AUS on different 
sized urethras may account for some of the variation in the individual responses measured, although a 
larger sample size would be required to demonstrate the importance of matching AUS and urethral 
size.  In humans, there was no effect in short-term incontinence following AUS placement with 
implants 4mm smaller or 4mm larger than the urethral circumference (Rothschild et al., 2014), 
suggesting that matching to exact urethral measurement may not be of clinical importance.  Use of the 
relatively larger cuff size was associated with improved long-term outcome (Rothschild et 
al.,2014).  While Adin and co-workers (2004) showed no significant variation in inflation between 
different occluders, the use of a different AUS in each cadaver may contribute to some individual 
variation between cadavers.  However, this method appeared preferable risking damage associated 
with repeated fixation and replacement that might have altered AUS performance if the same device 
was used repeatedly.  The study may have been improved by repeating the AUS placement and 
measurements of urethral pressures a further two more times on each cadaver to establish 
repeatability.  While a pattern has been observed in this dataset, it is not possible to confirm that the 
variability between dogs was due to difference in urethral size, or an intrinsic property of the AUS 
inflating around a soft tissue structure.  Collection of these additional data was limited due to time and 
resources, and therefore the results remain preliminary. 
The effect of incremental AUS inflation on maximum urethral pressure was not linear.  The manner 
of placement of the AUS around the urethra means that the occlusive effect during inflation is not 
concentric; instead, the leaves of the AUS hinge asymmetrically.  Depending on the size or relative 
position of the urethra within the AUS, the shape of the AUS will differentially affect urethral 
pressure.    Adin and co-workers (2004) demonstrated strong correlation between percentage 
occlusion of the AUS when not positioned around the urethra and incremental AUS filling, as 
determined by using digital images to calculate the resultant luminal area.  The use of percentage 
occlusion ex vivo is less useful clinically, as when the AUS is placed in situ, the "luminal area" can no 
longer be observed and entrapped soft tissues will alter filling profiles.  When placed around the 
urethra of cadavers and the AUS inflated with pre-determined volumes corresponding to reach 25% 
and 50% occlusion, a non-linear relationship between filling volume and mean cysto-urethral leak 
point pressure was observed, with significant difference from baseline cysto-urethral leak point 
pressure apparent at 50% occlusion (Adin et al., 2004).  The effect of incremental inflation on urethral 
pressure profilometry was not directly assessed. 
 It is beyond the scope of this study to determine whether a specific AUS 
volume can achieve continence in all cases of USMI but we provide here preliminary evidence of 
arelationship between AUS volume and maximal urethral pressure.  To fully determine the clinical 
significance of such a correlation, a further study evaluating urethral profilometry in clinical 
cases undergoing AUS placement filling is required. We have been able to show that use of small 
volume increments (0.15mL) is a valid approach and our preliminary data can be used as a benchmark 
to design the next study in live companion dogs. In fact, it can now be considered that researching the 
effect of incremental filling with use of aliquots ranging from 0.05mL to 0.1mL would be 
valuable The results of a clinical study would be able to direct clinicians as to whether incremental 
filling, use of urethral pressure profilometry, or use of clinical effect should be considered the 
recommended standard of care. 
  
CONCLUSION 
The placement of AUSs in cadavers was associated with a focal, non-linear increase in urethral 
pressure significantly correlated with AUS volume.  Although the correlation between maximal 
urethral pressure and AUS volume was significant in all cadavers, the magnitude of the response was 
different between individuals. This observation is also reflected in clinical experience of treating 
USMI with AUS placement.  These preliminary results suggest that incremental AUS inflation is 
suitable for the treatment of USMI butfurther investigation of UPP in live companion 
animals undergoing AUS placement is indicated for interpretation of the true impact of this data. 
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TABLES 
Cadaver Urethral 
circumference (mm) 
AUS inflation volume  
generating significant 
urethral pressure change 
after placement (mL) 
t value  
Dog 1 15 0.9 *  
1.05 † 
6.091 
20.56 
Dog 2 20 0.15* 
0.3 † 
0.45 † 
0.6 † 
0.75 † 
0.9 † 
1.05 † 
3.712 
10.09 
24.84 
36.98 
40.88 
40.88 
40.88 
Dog 3 25 0.6 † 
0.75 † 
0.9 † 
1.05 † 
3.665 
6.045 
16.13 
29.56 
Dog 4 20 0.75 † 
0.9 † 
1.05† 
9.995 
23.51 
37.27 
Dog 5 25 0.6 * 
0.75 † 
0.9 † 
1.05 † 
6.140 
13.61 
24.27 
31.36 
Table 1: This table displays, for each cadaver, the size of the urethra and the volumes of AUS 
inflation (after the priming volume) at which the urethral pressure change was increased significantly 
from that measured with a placed, but uninflated, AUS.   P <0.05 was used as the significance 
level, * denotes P <0.01, † denotes  P <0.001 .  The corresponding t values for each inflation are 
displayed.  In all cadavers, the maximum urethral pressure was recorded within the section of the 
urethra surrounded by the AUS. 
  
FIGURES 
Figure 1 : The line graphs (a) to (e) display the correlation between maximum recorded urethral 
pressure and incremental increases in AUS volume for each cadaver Dog 1 to 5 respectively.  Each of 
the three repeats for each recording is displayed along with a line joining the 
mean/span> recorded pressure.  The dotted line highlights the range of normal urethral pressures of 
104.6-188.4 cm H2O measured in conscious, continent dogs (Fischer et al., 2003), which can be 
focally exceeded in cadavers by the pressure exerted by filling of the AUS.  * denotes a significant 
increase in maximal urethral pressure compared to an uninflated cuff; P<0.05. 
 

 
